CD44 and cancer: We, therefore, asked the question, if the systemic treatment is likewise evoking CD44i35 elevation by comparison of CD44+ CRC data sets from the 8 non-treated cancer samples counting 79 cells declared as true negative with in total 6 samples including the treated mid-term and the completion cohort counting 78 cells, declared as true positive using AUC analysis.